Intelliject Aims To Build Combination Product Biz On Ease-Of-Use Benefits
This article was originally published in The Gray Sheet
Executive Summary
Human factors engineering has gained traction in the device industry in recent years, but Richmond-based Intelliject is a rare example of a firm trying to build a business around a focus on product usability
You may also be interested in...
New Biosimilar Approval Pathway Creates Device Opportunities
A new abbreviated regulatory pathway established by Congress for the approval of off-patent recombinant protein therapeutics could open up U.S. market opportunities for injection device technology firms
New Biosimilar Approval Pathway Creates Device Opportunities
A new abbreviated regulatory pathway established by Congress for the approval of off-patent recombinant protein therapeutics could open up U.S. market opportunities for injection device technology firms
New Biosimilar Approval Pathway Creates Device Opportunities
Several companies focusing on specialized injectors designed to improve patient comfort and compliance say their technologies will be crucial to differentiating biopharmaceutical products that are vying for the same patient population, but contain virtually the same active ingredient.